Synthesis, molecular modeling, and biology of the 1-benzyl derivative of APDC - an apparent mGluR6 selective ligand

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 5, 1997, Pages 601-606

  Tückmantel, Werner ^a   Kozikowski, Alan P ^a   Wang, Shaomeng ^a   Pshenichkin, Sergey ^a   Wroblewski, Jarda T ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 AMINO 1,3 CYCLOPENTANEDICARBOXYLIC ACID; 4 AMINO 1 BENZYL 2,4 PYRROLIDINEDICARBOXYLIC ACID; 4 AMINO 2,4 PYRROLIDINEDICARBOXYLIC ACID; 4 BENZAMIDO 2,4 PYRROLIDINEDICARBOXYLIC ACID; GLUTAMATE RECEPTOR; GLUTAMIC ACID; IONOTROPIC RECEPTOR; METABOTROPIC RECEPTOR; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHIRALITY; CHO CELL; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; GENE EXPRESSION; IN VITRO STUDY; MOLECULAR MODEL; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; REACTION ANALYSIS; STEREOCHEMISTRY;

EID: 0031552161     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)00068-1     Document Type: Article

References (30)

1. 1. Nakanishi, S. Science 1992, 258, 597.
2. 2. Nakanishi, S. Neuron 1994, 13, 1031.
3. 3. Reymann, K. G.; Matthies, H. Neurosci. Lett. 1989, 98, 166.
4. 4. Manahan-Vaughan, D.; Reiser, M.; Pin, J.-P.; Wilsch, V.; Bockaert, J.; Reymann, K. G.; Riedel, G. Neurosci. 1996, 72, 999.
5. 5. Aiba, A.; Cheng, C.; Herrup, K.; Rosenmund, C.; Stevens, C. F.; Tonegawa, S. Cell 1994, 79, 365.
6. 6. Opitz, T.; Richter, P.; Carter, A. J.; Kozikowski, A. P.; Shinozaki, H.; Reymann, K. G. Neurosci. 1995, 68, 989; Siliprandi, R.; Lipartiti, M.; Fadda, E.; Arban, R.; Kozikowski, A. P.; Manev, H. NeuroReport 1994, 5, 1227.
7. 6. Opitz, T.; Richter, P.; Carter, A. J.; Kozikowski, A. P.; Shinozaki, H.; Reymann, K. G. Neurosci. 1995, 68, 989; Siliprandi, R.; Lipartiti, M.; Fadda, E.; Arban, R.; Kozikowski, A. P.; Manev, H. NeuroReport 1994, 5, 1227.
8. 7. Kozikowski, A. P.; Tückmantel, W.; Liao, Y.; Manev, H.; Ikonomovic, S.; Wroblewski, J. T. J. Med. Chem. 1993, 36, 2706. For general reviews of the excitatory amino acid field, see: Drug Design for Neuroscience, Kozikowski, A. P., Ed.; Raven Press; New York, 1993.
9. 7. Kozikowski, A. P.; Tückmantel, W.; Liao, Y.; Manev, H.; Ikonomovic, S.; Wroblewski, J. T. J. Med. Chem. 1993, 36, 2706. For general reviews of the excitatory amino acid field, see: Drug Design for Neuroscience, Kozikowski, A. P., Ed.; Raven Press; New York, 1993.
10. 8. Riedel, G. Trends Pharmacol. Sci. 1996, 19, 219 and references cited therein.
11. 9. Ishida, M.; Saitoh, T.; Nakamura, Y.; Kataoka, K.; Shinozaki, H. Eur. J. Pharmacol. 1994, 268, 267.
12. 10. Jane, D. E.; Jones, P. L. St. J.; Pook, P. C.-K.; Tse, H.-W.; Watkins, J. C. Br. J. Pharmacol. 1994, 112, 809.
13. 11. Kozikowski, A. P.; Kiddle, J.; Steensma, D.; Wroblewski, J. T., manuscript in preparation.
14. 12. Schoepp, D. D.; Johnson, B. G.; Salhoff, C. R.; Valli, M. J.; Desai, M. A.; Burnett, J. P.; Mayne, N. G.; Monn, J. A. Neuropharmacol. 1995, 34, 843.
15. 13. Monn, J. A.; Valli, M. J.; Johnson, B. G.; Salhoff, C. R.; Wright, R. A.; Howe, T.; Bond, A.; Lodge, D.; Spangle, L. A.; Paschal, J. W.; Campbell, J. B.; Griffey, K.; Tizzano, J. P.; Schoepp, D. D. J. Med. Chem. 1996, 39, 2990.
16. 14. Monn, J. A.; Schoepp, D. D.; Valli, M. J. U. S. Patent 5,473,077, Dec. 5, 1995.
17. 15. Tanaka, K.; Sawanishi, H. Tetrahedron: Asym. 1995, 6, 1641.
18. -1, MeOH). Mp 105.5-107.5 °C (ref 15: mp 105-106 °C).
19. 2O)).
20. 2O).
21. 2O).
22. 20. Tanabe, Y.; Masu, M.; Ishii, T.; Shigemoto, R.; Nakanishi, S. Neuron 1992, 8, 169; Aramori, I.; Nakanishi, S. Neuron 1992, 8, 757; Abe, T.; Sugihara, H.; Nawa, H.; Shigemoto, R.; Mizuno, N.; Nakanishi, S. J. Biol. Chem. 1992, 267, 13361; Nakajima, Y.; Iwakabe, H.; Akazawa, C.; Nawa, H.; Shigemoto, R.; Mizuno, N.; Nakanishi, S. J. Biol. Chem. 1993, 268, 11868.
23. 20. Tanabe, Y.; Masu, M.; Ishii, T.; Shigemoto, R.; Nakanishi, S. Neuron 1992, 8, 169; Aramori, I.; Nakanishi, S. Neuron 1992, 8, 757; Abe, T.; Sugihara, H.; Nawa, H.; Shigemoto, R.; Mizuno, N.; Nakanishi, S. J. Biol. Chem. 1992, 267, 13361; Nakajima, Y.; Iwakabe, H.; Akazawa, C.; Nawa, H.; Shigemoto, R.; Mizuno, N.; Nakanishi, S. J. Biol. Chem. 1993, 268, 11868.
24. 20. Tanabe, Y.; Masu, M.; Ishii, T.; Shigemoto, R.; Nakanishi, S. Neuron 1992, 8, 169; Aramori, I.; Nakanishi, S. Neuron 1992, 8, 757; Abe, T.; Sugihara, H.; Nawa, H.; Shigemoto, R.; Mizuno, N.; Nakanishi, S. J. Biol. Chem. 1992, 267, 13361; Nakajima, Y.; Iwakabe, H.; Akazawa, C.; Nawa, H.; Shigemoto, R.; Mizuno, N.; Nakanishi, S. J. Biol. Chem. 1993, 268, 11868.
25. 20. Tanabe, Y.; Masu, M.; Ishii, T.; Shigemoto, R.; Nakanishi, S. Neuron 1992, 8, 169; Aramori, I.; Nakanishi, S. Neuron 1992, 8, 757; Abe, T.; Sugihara, H.; Nawa, H.; Shigemoto, R.; Mizuno, N.; Nakanishi, S. J. Biol. Chem. 1992, 267, 13361; Nakajima, Y.; Iwakabe, H.; Akazawa, C.; Nawa, H.; Shigemoto, R.; Mizuno, N.; Nakanishi, S. J. Biol. Chem. 1993, 268, 11868.
26. 21. Wroblewska, B.; Wroblewski, J. T.; Saab, O. H.; Neale, J. H. J. Neurochem. 1993, 61, 943.
27. 22. Monn, J. A.; Valli, M. J.; Wright, R. A.; Johnson, B. G.; Salhoff, C. R.; Mayne, N. G.; Burnett, J. P.; Helton, D. R.; Kallman, M. J.; Tizzano, J. P.; Schoepp, D. D. Neuropharmacol. 1996, 35, 81.
28. 23. QUANTA, a molecular modeling system, is supplied by Molecular Simulations, Inc., 200 Fifth Avenue,Waltham, MA 01803-5279.
29. 24. Brooks, B. R.; Bruccoleri, R. E.; Olafson, B. D.; States, D. J.; Swaminathan, S.; Karplus, M. J. Comput. Chem. 1983, 4, 187.
30. 25. For references to other recent work in the mGluR field, see: Costantino, G.; Pellicciari, R. J. Med. Chem. 1996, 39, 3998.